Co-infusion of mesenchymal stromal cells has no effect on relapse and infection in patients with leukemia undergoing haploidentical hematopoietic stem cell transplant

Leukemia and Lymphoma

Volumn 56, Issue 10, 2015, Pages 2965-2968

  Han, Dong Mei ^a   Wang, Zhi Dong ^a   Zheng, Xiao Li ^a   Ding, Li ^a   Yan, Hong Min ^a   Xue, Mei ^a   Zhu, Ling ^a   Liu, Jing ^a   Wang, Heng Xiang ^a  

^a AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; METHOTREXATE; MYCOPHENOLATE MOFETIL; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AIR FORCE; CANCER COMBINATION CHEMOTHERAPY; CHILD; EVENT FREE SURVIVAL; EX VIVO STUDY; FEMALE; GENERAL HOSPITAL; GRAFT VERSUS HOST REACTION; HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTESTINE FUNCTION; LETTER; LEUKEMIA; LEUKEMIA RELAPSE; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MESENCHYMAL STROMA CELL; NEUTROPHIL; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; UMBILICAL CORD; YOUNG ADULT; ADVERSE EFFECTS; COMPLICATION; CORD BLOOD STEM CELL TRANSPLANTATION; INFECTION; MESENCHYMAL STEM CELL TRANSPLANTATION; MORTALITY; PATHOLOGY; PROCEDURES; PROGNOSIS; RECURRENT DISEASE; SIBLING; TREATMENT OUTCOME;

CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFECTION; LEUKEMIA; MESENCHYMAL STEM CELL TRANSPLANTATION; PROGNOSIS; RECURRENCE; SIBLINGS; TREATMENT OUTCOME;

EID: 84947602148     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2015.1020061     Document Type: Letter

References (5)

1. Han DM, Liu J, Xue M, et al. Clinical analysis of the treatment of spinocerebellar ataxia and multiple system atrophy-cerebellar type with umbilical cord mesenchymal stromal cells. Cytotherapy 2011;13:913-917.
2. Wang H, Wang Z, Zheng X, et al. Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia - A single-center experience. Cytotherapy 2013;15:1118-1125.
3. Forslöw U, Blennow O, LeBlanc K, et al. Treatment with mesenchymal stromal cells is a risk factor for pneumonia?related death after allogeneic hematopoietic stem cell transplantation. Eur J Haematol 2012;89:220-227.
4. Lucchini G, Dander E, Pavan F, et al. Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation. Stem Cell Int 2012;2012:690236.
5. von Bahr L, Sundberg B, Lonnies L, et al. Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy. Biol Blood Marrow Transplant 2012;18: 557-564.